INVENTIVA (EPA:IVA) | WebDisclosure

Basculer en Français

10940	Companies
239029	Keywords
167904	Articles
128527	Press releases

Home
Companies
INVENTIVA

PRESS RELEASE

published on 07/31/2024 at 22:00, 2 years 1 month ago

Inventiva Reports Preliminary 2024 First-Half Financial Information¹
Inventiva reports preliminary 2024 first-half financial information, including cash position, expenses, and funding concerns. No revenues recorded in H1 2024. Company remains focused on clinical trials and upcoming milestones

Financial Information Cash Position Clinical Trials Inventiva Funding Concerns
PRESS RELEASE

published on 07/31/2024 at 22:00, 2 years 1 month ago

Inventiva publie ses informations financières préliminaires du premier semestre 2024¹
Inventiva publie ses informations financières préliminaires du premier semestre 2024, montrant une trésorerie de 10,1 millions d'euros et des flux nets de trésorerie, dépenses de R&D et émission de certificats de royalties

Premier Semestre Trésorerie Informations Financières Inventiva Certificats De Royalties
BRIEF

published on 07/25/2024 at 22:05, 2 years 1 month ago

Inventiva Secures Patent in Japan for Lanifibranor

Intellectual Property Japan Market Lanifibranor MASH/NASH Patent Approval
BRIEF

published on 07/25/2024 at 22:05, 2 years 1 month ago

Inventiva obtient un brevet au Japon pour Lanifibranor

Propriété Intellectuelle Marché Japonais Lanifibranor MASH/NASH Approbation Du Brevet
PRESS RELEASE

published on 07/25/2024 at 22:00, 2 years 1 month ago

Inventiva secures a new patent in Japan, expanding the IP protection of its lead product candidate lanifibranor
Inventiva secures a new patent in Japan for lanifibranor, enhancing IP protection for cirrhosis treatment, including MASH/NASH indication

Patent Japan Inventiva Lanifibranor Cirrhosis
PRESS RELEASE

published on 07/25/2024 at 22:00, 2 years 1 month ago

Inventiva obtient un nouveau brevet au Japon, élargissant la protection de la propriété intellectuelle de lanifibranor
Inventiva obtient un nouveau brevet au Japon pour lanifibranor, renforçant sa propriété intellectuelle dans le traitement de la cirrhose, y compris due à la MASH/NASH

Japon Brevet Inventiva Lanifibranor Cirrhose
BRIEF

published on 07/23/2024 at 10:56, 2 years 1 month ago

UBS Group dépasse le seuil de 5% du capital d'Inventiva

Droits De Vote Franchissement De Seuil Acquisition D'actions Inventiva UBS Group
BRIEF

published on 07/23/2024 at 10:56, 2 years 1 month ago

UBS Group exceeds the threshold of 5% of Inventiva's capital

Voting Rights Acquisition Of Shares Crossing Threshold Inventive UBS Group
PRESS RELEASE

published on 07/23/2024 at 10:51, 2 years 1 month ago

Franchissement de seuil
Déclaration de franchissement de seuil par UBS Group AG pour INVENTIVA avec 5,10% du capital et 4,08% des droits de vote, résultant d'une acquisition d'actions hors marché

Franchissement De Seuil Acquisition D'actions Inventiva UBS Group AG Hors Marché
BRIEF

published on 07/18/2024 at 08:35, 2 years 1 month ago

Inventiva annonce l'émission de certificats de royalties pour un montant de 20,1 millions d'euros

Biopharmaceutique Inventiva Lanifibranor MASH/NASH Certificats De Royalties

Accesswire

Published on 09/08/2026 at 01:45, 3 hours 31 minutes ago

Tunkillia Environmental Scoping Report Approved
Published on 09/05/2026 at 04:05, 3 days 1 hour ago

Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 3 days 5 hours ago

FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 3 days 6 hours ago

Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 3 days 6 hours ago

Panther Minerals Closes Brokered Private Placement of $3,000,000

View all ACCESSWIRE

EQS Group

Published on 09/07/2026 at 19:19, 9 hours 57 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Sales and Adjusted EBIT in Q2 2026/27 above prior-year level – FY outlook maintained
Published on 09/07/2026 at 19:00, 10 hours 16 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 31 août 2026 au 4 septembre 2026
Published on 09/07/2026 at 18:42, 10 hours 34 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/07/2026 at 18:00, 11 hours 16 minutes ago

E-PANGO: e-Pango organise un webinaire avec ses actionnaires
Published on 09/07/2026 at 17:45, 11 hours 31 minutes ago

VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social

Les Echos

Published on 09/07/2026 at 19:55, 9 hours 20 minutes ago

TFF GROUP CREE TFF UPCYCLING
Published on 09/07/2026 at 19:00, 10 hours 16 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 4 septembre 2026
Published on 09/07/2026 at 19:00, 10 hours 16 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of September 4, 2026
Published on 09/07/2026 at 18:05, 11 hours 11 minutes ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/08/2026
Published on 09/07/2026 at 18:05, 11 hours 11 minutes ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/08/2026

View all LES ECHOS COMFI WIRE